Literature DB >> 7803853

Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.

P Savagner1, A M Vallés, J Jouanneau, K M Yamada, J P Thiery.   

Abstract

We described previously that acidic fibroblast growth factor (aFGF), but not basic fibroblast growth factor (bFGF), can induce the rat carcinoma cell line NBT-II to undergo a rapid and reversible transition from epithelial to mesenchymal phenotype (EMT). We now find that NBT-II EMT is stimulated by keratinocyte growth factor (KGF) in cells grown at low density. Accordingly, a high-affinity receptor showing 98% homology to mouse FGF receptor 2b/KGF receptor was cloned and sequenced from NBT-II cells. Northern analysis indicated that mRNA for FGF receptor 2b/KGF receptor was drastically down-regulated within 1 wk in aFGF-induced mesenchymal NBT-II cells. This decrease coincided with an up-regulation of FGF receptor 2c/Bek, a KGF-insensitive, alternatively spliced form of FGF receptor 2b/KGF receptor. Functional studies confirmed that KGF could not maintain EMT induction on mesenchymal NBT-II cells. FGF receptor 1 and FGF receptor 2c/Bek could also support EMT induction when transfected into NBT-II cells in response to aFGF or bFGF. Such transfected cells could bind bFGF as well as aFGF. Therefore, EMT can be induced through different FGF receptors, but EMT may also regulate FGF receptor expression itself.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7803853      PMCID: PMC301106          DOI: 10.1091/mbc.5.8.851

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  55 in total

1.  Signal transduction defect appears to be the cause of rat prostate cancer cell fibroblast growth factor insensitivity.

Authors:  S A Shain; A L Lin; G Wong
Journal:  Cell Growth Differ       Date:  1992-10

2.  Different members of the fibroblast growth factor receptor family are specific to distinct cell types in the developing chicken embryo.

Authors:  G Patstone; E B Pasquale; P A Maher
Journal:  Dev Biol       Date:  1993-01       Impact factor: 3.582

Review 3.  Structural and functional specificity of FGF receptors.

Authors:  J Partanen; S Vainikka; K Alitalo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1993-06-29       Impact factor: 6.237

4.  A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF.

Authors:  A Mansukhani; D Moscatelli; D Talarico; V Levytska; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

5.  Alternating phases of FGF receptor and NGF receptor expression in the developing chicken nervous system.

Authors:  J G Heuer; C S von Bartheld; Y Kinoshita; P C Evers; M Bothwell
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

6.  Optimal spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase.

Authors:  J R Feramisco; D B Glass; E G Krebs
Journal:  J Biol Chem       Date:  1980-05-10       Impact factor: 5.157

7.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

Authors:  T Miki; D P Bottaro; T P Fleming; C L Smith; W H Burgess; A M Chan; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

8.  Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.

Authors:  A T Chellaiah; D G McEwen; S Werner; J Xu; D M Ornitz
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

9.  FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.

Authors:  J Partanen; T P Mäkelä; E Eerola; J Korhonen; H Hirvonen; L Claesson-Welsh; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice.

Authors:  L Guo; Q C Yu; E Fuchs
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  45 in total

1.  Exo70 isoform switching upon epithelial-mesenchymal transition mediates cancer cell invasion.

Authors:  Hezhe Lu; Jianglan Liu; Shujing Liu; Jingwen Zeng; Deqiang Ding; Russ P Carstens; Yusheng Cong; Xiaowei Xu; Wei Guo
Journal:  Dev Cell       Date:  2013-12-09       Impact factor: 12.270

Review 2.  Alternative splicing of DNA damage response genes and gastrointestinal cancers.

Authors:  Bahityar Rahmutulla; Kazuyuki Matsushita; Fumio Nomura
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 3.  Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT).

Authors:  A S Martínez-Ramírez; M Díaz-Muñoz; A Butanda-Ochoa; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2016-11-29       Impact factor: 3.765

Review 4.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

Review 5.  Connecting the dots: chromatin and alternative splicing in EMT.

Authors:  Jessica A Warns; James R Davie; Archana Dhasarathy
Journal:  Biochem Cell Biol       Date:  2015-07-07       Impact factor: 3.626

Review 6.  Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

Authors:  A Sveen; S Kilpinen; A Ruusulehto; R A Lothe; R I Skotheim
Journal:  Oncogene       Date:  2015-08-24       Impact factor: 9.867

7.  Splicing reporter mice revealed the evolutionally conserved switching mechanism of tissue-specific alternative exon selection.

Authors:  Akihide Takeuchi; Motoyasu Hosokawa; Takayuki Nojima; Masatoshi Hagiwara
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

Review 8.  The role of Snail in prostate cancer.

Authors:  Bethany N Smith; Valerie A Odero-Marah
Journal:  Cell Adh Migr       Date:  2012-09-01       Impact factor: 3.405

9.  Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.

Authors:  Thomas Amann; Frauke Bataille; Thilo Spruss; Katja Dettmer; Peter Wild; Christian Liedtke; Marcus Mühlbauer; Paul Kiefer; Peter J Oefner; Christian Trautwein; Anja-Katrin Bosserhoff; Claus Hellerbrand
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 10.  Fibroblast growth factor signalling: from development to cancer.

Authors:  Nicholas Turner; Richard Grose
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.